#1
Posted: Mon Apr 06, 2026 6:01 pm
Medicaid insurance expansions between 2017 and 2023 sharply increased access to medication treatment for opioid use disorder in a period when fatal overdoses continued to climb, according to Rutgers Health researchers. Their study, published in JAMA Network Open, finds that expanded Medicaid coverage yielded meaningful population-level increases in the use of buprenorphine, a medication used to treat opioid use disorder.
Source: https://medicalxpress.com/news/2026-04- ... tment.html
Source: https://medicalxpress.com/news/2026-04- ... tment.html